So, as we can see here synaptic loss is not just age related and we can see this relationship through the evidence of the parts of the brains affected as well as a study that looks at an actual comparison of synapses. The comparison is between people with no cognitive impairment, mild cognitive impairment, and early Alzheimer’s disease. Mild cognitive impairment is a type of impairment within the brain that can cause a slight but noticeable decline in cognitive abilities. These abilities include memory and thinking skills. These patients are at a higher risk of developing Alzheimer’s and that is why they were also looked at in this research (Scheff, Price, Schmitt & Mufson, 2005). One of the major research findings that led to this study was that patients with Alzheimer’s disease seemed to have a loss of synaptic contacts in their neocortex and hippocampus. This loss of synaptic contacts demonstrates an association with cognitive ability and correlates strongly with dementia. It was unknown whether patients with mild cognitive impairment had significant synaptic loss compared to those with no cognitive impairment.
Twenty-eight individuals agreed to participate in this longitudinal clinical pathological study of gaining in Alzheimer’s disease. They agreed to annual clinical evaluations as well as to donate their brain to the research once they had died. The average age of the participants was 85 and the range was from 66 to 103. The annual clinical evaluation was to assess what group the participant belonged to. Obviously there was a specific criterion to check for if a person fell under the early Alzheimer’s category. There was no official criterion for those with mild cognitive impairment so those who fell under that category w...
... middle of paper ...
...between only the mild cognitive impairment patients and the no cognitive impairment patients. This seems to be a precursor for the rest of the results as well. When it came to the number of synapses found there was a significant difference found between the early Alzheimer’s disease (eAD) patients and the mild cognitive ability (MCI) and no cognitive ability (NCI) patients. The eAD group was 36% lower than the other groups. There was no significant difference between the MCI and NCI groups even though the NCI group had 13% lower number synapses. Lastly, there was a significant difference between group means in the volume in eAD with MCI and NCI. Early Alzheimer’s was 20% lower than MCI, respectively and 22% lower than NCI. Once again, there was no significant finding between MCI and NCI groups in terms of the synaptic density (Scheff, Price, Schmitt & Mufson, 2005).
Memory plays a significant role in the everyday lives of people of all ages. It allows them to recall information and remember skills that were learned in the past. Memory also organizes past information to help people make current and future decisions. However, imagine forgetting the names of close family members or not having the ability to find your keys every time you want to leave the house. These are some of the struggles that people with Alzheimer’s disease face daily. Alzheimer’s disease was first identified by German neurologist Alois Alzheimer in 1906, and was discovered to have an overpowering effect on explicit memory loss (Gruetzner, 1988). There are two types of Alzheimer’s disease – early onset and late onset. Early onset occurs in patients who are diagnosed before the age of 65 whereas late onset occurs in patients who are diagnosed after the age of 65. In the early stages of Alzheimer’s disease, short-term memory is often lost. As Alzheimer’s disease progresses, problems with long-term memory begin to develop, in addition to short-term memory impairments. Although a lot is known about the symptoms of Alzheimer’s disease, the cause has not been conclusively identified. However, as research continues, new theories about the cause of Alzheimer’s disease are being proposed. This has led to a controversy over whether Alzheimer’s disease is caused by genetics or environmental influences (Gruetzner, 1988).
performance that involves, but is not limited to, a loss in at least 2 of the
Alzheimer’s disease is a complex illness that affects the brain tissue directly and undergoes gradual memory and behavioral changes which makes it difficult to diagnose. It is known to be the most common form of dementia and is irreversible. Over four million older Americans have Alzheimer’s, and that number is expected to triple in the next twenty years as more people live into their eighties and nineties. (Johnson, 1989). There is still no cure for Alzheimer’s but throughout the past few years a lot of progress has been made.
...tions in the number of synaptic spines and functional synapses contribute to annual reductions of as much as 0.5% to 1.0% in cortical thickness (the cortex is the outermost layer of the brain) and sub-cortical volume in some regions of the brain (Fjell & Walhovd, 2010). Working memory declines in both speed and function, so they forget names, locations of important objects, appointments and medication schedules (Smart, 2012). Both physical fitness and exercise in the form of stimulation among multiple channels aid in slowing cognitive decline and could potentially provide success to individuals (Whitbourne & Whitbourne, 2010). However, Horn and Cattell found that memory, crystallized intelligence, and fluid knowledge all decreased after age of 70 despite level of education, physical activeness and the number and variety of stimulating experiences (Smart, 2012).
In this day and age, it seems as though almost everyone has experience a loved one taken away form a very serious disease known as Alzheimer’s disease. Alzheimer’s disease is unbelievably devastating for everyone affected by it. This disease is causing major economical problems such as less occupancy in the nursing homes, and hospitals due to the rising population of elderly men and women being diagnosed with it everyday. Because there is not yet a cure for this disease and the percent of the population being diagnosed keeps rapidly rising, more time and money needs to go towards Alzheimer’s research.
Alzheimer's Disease Introduction to Alzheimer's Alzheimer's disease is a progressive, degenerative disease of the brain. It was first described by the German neuropathologist Alois Alzheimer (1864-1915). in 1905. This disease worsens with advancing age, although there is no evidence. that it is caused by the aging process.
tends to increase with age, but there is a big difference between normal forgetfulness and Alzheimer's disease. There are three things to know about Alzheimer's: the facts and figures, the seven stages, and the changes in the brain.
Alzheimer’s disease progresses at a very slow rate. Changes in the brain may begin to develop as much as twenty years before diagnosis [2] (Figure 1a). Mild to moderate Alzheimer’s (Figure 1b) may last two to ten years [2]. In this stage, there is very mild cognitive impairment including memory lapses in association with familiar words or location of objects...
There are three stages towards Alzheimer’s and one should be aware of the important signs and symptoms. For instance, one should be aware of co...
Alzheimer’s disease, named after Dr. Alois Alzheimer, is a disease that is on the rise in America and the rest of the world. People should learn as much as they want about this disease, because as you age, your chances of becoming an Alzheimer’s Disease, or AD, patient increases. It is estimated that approximately 3 percent of Americans between the ages of 65 and 74 have the illness, and more than half of all people over age 85 have the ailment.
Alzheimer’s disease (AD) is a progressive, terminal, degenerative brain disease. It is the fourth leading cause of death in adults and currently affects over four million people in the United States. This number is expected to increase over the next several years as the baby boomers age, until it reaches fourteen million by the year 2025.
WIMO, A., WINBLAD, B., AGUERO-TORRES, H. & VON STRAUSS, E. 2003. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord, 17, 63-7.
A healthy brain can have normal aging. A normal cognitive aging leads to predictable changes in thinking and memory that are associated with getting older (Memory impairment. (2010). The normal “healthy” brain aging is defined as aging without disease. Many elderly people do not exhibit symptoms of disease and live a normal, but never less they may display a little forgetfulness (Perlmutter, David. (2004). The normal brain aging differs from pathological aging caused by diseases that damage the brain, such as Alzheimer’s or cerebrovascular disease (Me...
There are four main types of dementia with AD being the most widespread form. It ac...
When disease progression reaches minor to moderate AD, patients undergo a decline in the aptitude to process complex thoughts (e.g. experiencing predicaments cooking a meal or balancing the checkbook), more prominent memory loss (e.g. misunderstandings regarding familiar places and trouble recalling otherwise well-known names), as well as personality and mood changes. Anatomically, atrophy spreads to additional areas of the cerebral cortex (Figure 3) (Alzheimer’s